Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 853.35B, Eli Lilly(LLY) trades at $906.44. The stock has a price-to-earnings ratio of 40.08 and currently yields dividends of 67.7%.
During the trading session on 2026-04-22, Eli Lilly(LLY) shares reached a daily high of $923.05 and a low of $881.11. At a current price of $906.44, the stock is +2.9% higher than the low and still -1.8% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 4.06M, versus its average volume of 2.7M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
An Eli Lilly Zepbound injection pen. Shelby Knowles / Bloomberg News The Medicare agency will extend a short-term program that will pay for weight-loss drugs s...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analysts at Swiss bank UBS Group (UBS) are urging investors to buy Eli Lilly (LLY) stock after the pharma giant announced it is paying $7 billion to acquire can...
Analyst ratings
83%
of 35 ratingsMore LLY News
Shares of Eli Lilly (LLY) and Novo Nordisk (NVO) are under pressure on Tuesday after CVS Health (CVS) announced the company’s decision regarding Medicare obesit...
Eli Lilly and Novo Nordisk's Newest Rival In Weight Loss? Amazon. 3:58 AM ET Shares of Eli Lilly, Novo Nordisk and Viking Therapeutics tumbled Tuesday after Am...
Key Points Eli Lilly is spending some of its GLP-1 money to buy up CAR-T gene therapy researchers. UBS analyst Michael Yee thinks that's smart strategy. 10 s...
Key Points Novo Nordisk and Eli Lilly are largely responsible for creating today's weight-loss drug market. The two companies, however, can’t fend off creativ...
Eli Lilly (NYSE:LLY) has agreed to acquire Kelonia Therapeutics in a transaction valued at up to $7b. The deal expands Eli Lilly's presence in in vivo CAR T ce...
Eli Lilly is making a bold move, agreeing to acquire Kelonia Therapeutics in a deal worth up to $7 billion, with billions tied to future milestones and a plans....
Technology Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, Others Licensing Eli Lilly (LLY) said Monday it will spend up to $7 billion to buy priva...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.